# The effect of short-term consumption of Bifidobacterium bifidum on the gut microbiome of obese individuals

**Authors:** Inna Burakova, Yuliya Smirnova, Polina Morozova, Svetlana Pogorelova, Olga Kryukova, Tatiana Kislova, Olga Korneeva, Mikhail Syromyatnikov

PMC · DOI: 10.3389/ebm.2026.10894 · Experimental Biology and Medicine · 2026-02-23

## TL;DR

This study shows that a probiotic containing Bifidobacterium bifidum can positively affect the gut microbiome of obese individuals.

## Contribution

The novel finding is the specific positive impact of Bifidobacterium bifidum on several gut bacteria in obese individuals.

## Key findings

- The probiotic supplement increased the abundance of beneficial gut bacteria like Bacteroides uniformis and Alistipes putredinis.
- The study suggests Bifidobacterium bifidum may help treat gut microbiota dysbiosis in obesity.

## Abstract

It is known that gut microbiota dysbiosis can lead to obesity by disrupting energy consumption and metabolism. Probiotic supplements are a potential therapeutic option for improving intestinal homeostasis. The aim of this study was to investigate the effect of a probiotic supplement containing Bifidobacterium bifidum on the intestinal microbiome of people with obesity using high-throughput sequencing on the DNBSEQ-G50 platform. The study demonstrated a positive effect of the supplement on bacterial species such as Bacteroides uniformis, Alistipes putredinis, Alistipes shahii, Dysosmobacter welbionis, and Gemmiger formicilis. Therefore, we suggest the potential use of this bacterial species in the treatment of gut microbiota dysbiosis of obese individuals.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)
- **Species:** Bifidobacterium bifidum (taxon 1681), Bacteroides uniformis (taxon 820), Alistipes putredinis (taxon 28117), Alistipes shahii (taxon 328814), Dysosmobacter welbionis (taxon 2093857), Gemmiger formicilis (taxon 745368)

## Full-text entities

- **Diseases:** cardiovascular diseases (MESH:D002318), Crohn's disease (MESH:D003424), colitis (MESH:D003092), insulin resistance (MESH:D007333), hypertension (MESH:D006973), colorectal cancer (MESH:D015179), ulcerative colitis (MESH:D003093), colon diseases (MESH:D003108), infectious (MESH:D003141), type 2 diabetes mellitus (MESH:D003924), inflammatory bowel disease (MESH:D015212), heart disease (MESH:D006331), mental disorders (MESH:D001523), cancer (MESH:D009369), diabetes (MESH:D003920), dysbacteriosis (MESH:D064806), liver fibrosis (MESH:D008103), headache (MESH:D006261), inflammation (MESH:D007249), metabolic syndromes (MESH:D024821), metabolic disorders (MESH:D008659), fatty liver disease (MESH:D005234), obese (MESH:D009765), overweight (MESH:D050177)
- **Chemicals:** butyrate (MESH:D002087), amino acid (MESH:D000596), propionate (MESH:D011422), carbohydrates (MESH:D002241), J115T (-), acetate (MESH:D000085), SCFAs (MESH:D005232), butyric acid (MESH:D020148), fat (MESH:D005223)
- **Species:** Alistipes (genus) [taxon 239759], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Alistipes shahii (species) [taxon 328814], Homo sapiens (human, species) [taxon 9606], gut metagenome (species) [taxon 749906], Bifidobacterium bifidum (species) [taxon 1681], Gemmiger formicilis (species) [taxon 745368], Alistipes putredinis (species) [taxon 28117], Mus musculus (house mouse, species) [taxon 10090], Bifidobacterium longum (species) [taxon 216816], Bacteroides uniformis (species) [taxon 820], Dysosmobacter welbionis (species) [taxon 2093857]
- **Cell lines:** FCL — Chlorocebus aethiops (Green monkey), Finite cell line (CVCL_4159)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968040/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968040/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968040/full.md

---
Source: https://tomesphere.com/paper/PMC12968040